An Adolescent Female Presenting with Classical Clinical and Immunological Features of Isoniazid Induced Lupus
DOI:
https://doi.org/10.21276/txy54d22Keywords:
Isoniazid, Tuberculosis, Drug Induced LupusAbstract
Drug induced Lupus Erythematosus (DILE) is a form of rare adverse drug reaction caused due to many drugs, including Isoniazid. Diagnosis is made on the basis of a temporal relationship between the drug administered and the onset of symptoms and on the basis of the antibody profile. We describe the case of a 13 year old female who was diagnosed as having abdominal tuberculosis and was put on ATT and later presented with signs and symptoms of Lupus Erythematosus, with a history of photosensitivity, oral ulcers, and malar rash.
Downloads
References
Lee S L, Chase P H. Drug-induced systemic lupus erythematosus: a critical review. Semin Arthritis Rheum 1975; 5: 83-103
Weinstein A. Drug-induced lupus erythematosus. Prog Clin Immunol 1980; 4: 1-21.
Nolan CM, Goldberg SV, Buskin SE. Hepatotoxicity associated with isoniazid preventive therapy: A 7-year survey from a public health tuberculosis clinic. JAMA. 1999; 281: 1014-1018.
Shah BR, Santucci K, Sinert R, Steiner P. Acute isoniazid neurotoxicity in an urban hospital. Pediatrics. 1995; 95: 700-704.
Shah R, Ankale P, Sinha K, Iyer A, Jayalakshmi TK. Isoniazid induced lupus presenting as oral mucosal ulcers with pancytopenia. J Clin Diagn Res. 2016; 10: OD03-OD5.
Preziosi P. Isoniazid: Metabolic aspects and toxicological correlates. Curr Drug Metab. 2007; 8: 839-851.
Pretel M, Marquès L, España A. Drug-induced lupus erythematosus. Actas Dermo-Sifiliográficas (English Edition). 2014;105(1):18–30.
Millard TP, McGregor JM. Molecular genetics of cutaneous lupus
erythematosus.Clin Exp Dermatol 2001;26:184–91.
Merola J. Lupus-Like Syndromes Related to Drugs. In: Schur P, ed. by.
Lupus Erythematosus Clinical Evaluation and Treatment. 1st ed. 2012. p. 211–221.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 International Archives of BioMedical and Clinical Research
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors are required to sign and submit the completed “Copyright transfer Form” upon acceptance of publication of the paper. This is determined by a publishing agreement between the author and International Archives of Biomedical and Clinical Research. These rights might include the right to publish, communicate and distribute online. Author(s) retain the copyright of their work. International Archives of Biomedical and Clinical Research supports the need for authors to share, disseminate and maximize the impact of their research.
